|
D.V. Bestaev, A.A. Konushkaliev, E. Mokhamed Hussein
Methotrexate and early rheumatoid arthritis
|
№13 / 2022
|
|
O.D. Guryeva, M.I. Savelyeva, T.T. Valiev
Influence of pharmacogenetic parameters on clinical variants of methotrexate toxicity in acute lymphoblastic leukemia in children
|
№7 / 2022
|
|
O.N. Sutugina (1), L.B. Shubin (2), M.B. Okhapkin (1)
Retrospective evaluation of the experience of using methotrexate in the treatment of ectopic pregnancy
|
№6 / 2021
|
|
S.S. Dotsenko, L.N. Shilova
CLINICAL AND LABORATORY PREDICTORS OF EFFECTIVENESS OF BACKGROUND THERAPY IN RHEUMATOID ARTHRITIS
|
№19 / 2017
|
|
O.G. Filimonova, O.V. Simonova
DYNAMICS OF PSYCHOEMOTICAL STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS AGAINST THE BACKGROUND OF DISEASE-MODIFYING THERAPY
|
№s3-17 / 2017
|
|
E.N. Sukhikh, O.V. Simonova
CONCENTRATIONS OF STABLE METABOLITES OF NITRIC OXIDE IN THE SERUM AND URINE OF PATIENTS WITH ANKILOSING SPONDYLOARTHRITIS
|
№7 / 2017
|
|
I.M. Marusenko
EXPERIENCE OF THE USE OF GENETICALLY ENGINEERED BIOLOGIC DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AFTER TOFACITINIB
|
№7 / 2017
|
|
T.V. Korotaeva
ADVANCES IN THE TREATMENT OF PSORIATIC ARTHRITIS
|
№7 / 2015
|
|
N.V. Chichasova, G.R. Imametdinova
CURRENT TREATMENT OF RHEUMATOID ARTHRITIS: RECOMMENDATIONS AND ACTUAL PRACTICE
|
№19 / 2014
|
|
T.V. Korotaeva
CURRENT TREATMENT OF PSORIATIC ARTHRITIS
|
№20 / 2013
|
|
Yu.V.Muravyev
RATIONAL TREATMENT OF RHEUMATOID ARTHRITIS
|
№19 / 2013
|
|
V.V. Badokin
Efficacy And Tolerability Of Methotrexate In Psoriatic Arthritis
|
№19 / 2012
|
Русский
